Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

tenofovir loaded stearyl amine modified bolaamphiphilic nanovesicle

Based on

1 Patents
2014 Most recent source

Composition

1

Tris buffer

TB
Type Complex Compound
Formula
Role core
2

({[(2R)-l-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid

({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid (R)-9-(2-phosphonylmethoxypropyl)-adenine (R)-9-[2-(phosphonomethoxy)propyl]adenine tenofovir Viread® PMPA TNF TFV
Type Single Compound
Formula C9H14N5O4P
Role loaded material
3

bolaamphiphilic compound-lipid mixture

Type Complex Compound
Formula
Role layer
4

1-octadecylamine

octadecylamine stearylamine ODA
Type Single Compound
Formula C18H39N
Role layer

Properties

General physical and chemical properties

Property Value Source
tenofovir encapsulation

0 more entry available to subscribes only.

Or, view sample content

Applications

Area Application Source
drug delivery

1 more entry available to subscribes only.

Or, view sample content

Characterization

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • {2-[(5-{[(9E)-7-hydroxy-17-({11-[(9E)-12-hydroxy-13-({5-oxo-5-[2-(trimethylazaniumyl)ethoxy]pentanoyl}oxy)octadec-9-enamido]undecyl}carbamoyl)heptadec-9-en-6-yl]oxy}-5-oxopentanoyl)oxy]ethyl}trimethylazanium dichloride
  • cholesteryl hemisuccinate
  • cholesterol
See all (5)
  1. wnIwLOJcZj
Product

tenofovir loaded stearyl amine modified bolaamphiphilic nanovesicle

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial